Paul J. Clancy
2017
In 2017, Paul J. Clancy earned a total compensation of $3.7M as Former Executive Vice President, Finance and Chief Financial Officer at Biogen, a 32% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $61,983 |
|---|---|
| Salary | $458,945 |
| Stock Awards | $2,961,929 |
| Other | $168,361 |
| Total | $3,651,218 |
Clancy received $3M in stock awards, accounting for 81% of the total pay in 2017.
Clancy also received $62K of change in pension value and nonqualified deferred compensation earnings, $458.9K in salary and $168.4K in other compensation.
Rankings
In 2017, Paul J. Clancy's compensation ranked 2,876th out of 14,666 executives tracked by ExecPay. In other words, Clancy earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,876 out of 14,666 | 80th |
Division Manufacturing | 987 out of 5,772 | 83rd |
Major group Chemicals And Allied Products | 263 out of 2,075 | 87th |
Industry group Drugs | 201 out of 1,731 | 88th |
Industry Biological Products, Except Diagnostic Substances | 37 out of 313 | 88th |
Source: SEC filing on April 27, 2018.
Clancy's colleagues
We found eight more compensation records of executives who worked with Paul J. Clancy at Biogen in 2017.
2017
Michel Vounatsos
Biogen
Chief Executive Officer
2017
George Scangos
Biogen
Chief Executive Officer
2017
Kenneth DiPietro
Biogen
Former Executive Vice President, Human Resources
2017
Michael Ehlers
Biogen
Executive Vice President, Research & Development
2017
Susan Alexander
Biogen
Chief Legal Officer
2017
Paul McKenzie
Biogen
Executive Vice President, Pharmaceutical Operations & Technology
2017
Gregory Covino
Biogen
Chief Accounting Officer
2017
Jeffrey Capello
Biogen